Gujarat Cancer & Research Institute

The Gujarat Cancer & Research Institute scored 88.71 for teaching, learning and resources in the NIRF 2025 medical ranking and 7.00 for perception. That teaching score ties Madras Medical College for the fifth highest of the 50 institutions on the list, while the perception score is the third lowest, so the training is rated with the country's best and almost nobody outside oncology has heard of the place. GCRI admits no MBBS batch, so nobody arrives here out of school. Entry starts at MD, DM, MCh, an institute fellowship or a paramedical qualification, and the degree at the end carries Gujarat University's name rather than the institute's.

GCRI is a hospital first and a teaching body second, and its founding sequence shows it. Outpatient services opened in October 1965 and the wards in April 1967, and the tripartite agreement between the Government of Gujarat and the Gujarat Cancer Society that made it an autonomous institution was signed in February 1972, the year it counts as its founding. The Gujarat Cancer Society behind it grew out of a cultural evening run by the Inner Wheel Club of Ahmedabad and was founded on 2 April 1961; the state gave four acres inside the New Civil Hospital compound in January 1962, then another 3.3 acres after the Wahi committee, appointed by the Government of India to judge where cancer hospitals were needed, recommended in May 1972 that this one be built up into a regional cancer hospital and research centre.

What it is today depends on which register you open, and the difference matters to anyone weighing a private fee against a government one. The institute's own account calls it a joint venture of the Government of Gujarat and the Gujarat Cancer Society, affiliated to B J Medical College, and a State Cancer Institute recognised by the Union Ministry of Health and Family Welfare, and its homepage adds that it takes support under the National Cancer Control Programme as a regional cancer centre. The education ministry's All India Survey on Higher Education, by contrast, still files it under Gujarat University as a recognised centre whose management type is recorded as private un-aided. The governing board is what settles the question in practice, because it seats the state's principal secretary for health and family welfare and other serving officials alongside nominees of the Gujarat Cancer Society, so the control is shared rather than private whatever the survey field says.

Every course on GCRI's list sits above the MBBS line or beside it in the paramedical sciences, and the clinical teaching splits three ways: oncology super-specialty programmes, five MD subjects, and the institute's own fellowships. The approved super-specialty seats are narrow and deliberately so, since each one exists to produce a cancer specialist rather than a general physician.

The MD side is where a fresh MBBS graduate enters, and the institute reports it as admissions rather than as a standing sanction, so the figures below are what it last took in rather than a promise for the coming cycle.

The paramedical courses are the only ones at GCRI with a published price, and the sheet is unusually specific about it.

Two things in that table deserve a second look. The fees are gendered, with no explanation printed beside them, so a woman pays Rs 10,800 a semester for the M.Sc. in Cancer Biology where a man pays Rs 12,150, and Rs 12,000 against Rs 13,500 in Medical Physics. The clinical fee is simply missing. Nothing on that sheet prices an MD, DM or MCh seat, and GCRI is not one of the institutions the state admission committee prices either.

What that committee does price is the college GCRI's MD teaching hangs off. Its fee notification for the 2025 postgraduate cycle sets one government-quota tuition figure of Rs 1,30,800 across every MD branch at B. J. Medical College, Ahmedabad. That is the seat's fee and not GCRI's own charge, so treat it as the order of magnitude and get the exact amount in writing from the teaching department before accepting a place.

Financial help is thin on the record. The institute's NIRF 2025 return shows 90 postgraduate students on roll and none of them receiving full tuition fee reimbursement, whether from state and central government funds, from the institution itself, or from private bodies.

Which exam you sit depends on which teaching line you are aiming at, and none of them is NEET-UG. The institute's annual report sets the affiliation out plainly: B J Medical College and Gujarat University cover the DM and MCh teaching in medical oncology, oncopathology, gynaecological oncology and surgical oncology, and the MD teaching in microbiology, radiodiagnosis, anaesthesiology and radiation oncology, while Gujarat University separately recognises the M.Sc. in Cancer Biology, the M.Sc. in Medical Physics and the PhD in life sciences.

A super-specialty seat is decided entirely outside Gujarat. NEET-SS is the single entrance examination prescribed for DM, MCh and DrNB super-specialty admission under the National Medical Commission Act, and no other test at state or institution level is valid for entry, with NBEMS conducting it. The allotment that follows is not GCRI's to make either, because the Medical Counselling Committee's scheme records that the Directorate General of Health Services counsels 100% of super-specialty seats in state government institutions, deemed universities and trust or society institutions alike, over two rounds. You register on the MCC portal, lock your choices, and take what merit gives you.

An MD place is harder to trace, and the honest answer is that the seat is not filed under GCRI's name. The institute does not appear as an institution in the Gujarat admission committee's seat matrix for the 2025 MD and MS cycle, and the five MD subjects GCRI teaches sit in that document under B. J. Medical College, Ahmedabad, the college its own annual report names as its affiliating college. Entry is on NEET-PG merit through the counselling that covers those seats, run by the Admission Committee for Professional Post Graduate Medical Educational Courses under the state's 2007 admissions Act, so the branch to watch in the schedule carries B. J. Medical College's name rather than GCRI's, and it is worth asking the department outright which institution your seat will be recorded against.

The fellowships are GCRI's own award, and the FNB in paediatric haemato-oncology comes from the National Board of Examinations rather than the university. For the paramedical courses the bar sits on the same course sheet: a B.Sc. carrying biological science subjects for Cancer Biology, a B.Sc. in physics with at least 60% for Medical Physics, and at least 50% for both the PGDMLT and the CMRT certificate, the latter approved by the Technical Education Board at Gandhinagar and the Atomic Energy Regulatory Board. What GCRI does not publish is a calendar. There is no online application portal, no window and no prospectus for these courses on its website, so the teaching department itself is the only reliable place to ask when the next intake opens.

No cutoff is set at GCRI, and there is no NEET-UG closing rank to look up because nobody is admitted at that level. A DM or MCh place turns on the NEET-SS closing rank in that specialty, published by the Medical Counselling Committee after each of its two rounds.

The MD closing rank is the one that goes missing, and knowing why saves a lot of searching. GCRI is not a listed institution in the Gujarat committee's institute-wise last-rank list for the 2025 postgraduate round, so no line in it reads GCRI; the subjects taught here close under B. J. Medical College's rows, category by category and quota by quota.

Scale is the other thing to understand. Ten DM Medical Oncology seats and four MCh Gynaecological Oncology seats make a very small denominator, and in branches that size a couple of candidates upgrading or withdrawing between rounds moves the last rank further than a year of shifting demand would. A GCRI specialty can therefore read far harder or far easier than it is on any single year's figure, which is why the movement between round one and round two tells you more than the closing number itself.

Nobody is recruited at GCRI in the campus sense, and the institute reports its outcomes the way a residency programme does, counting who finished in time, who took a post and who went on to train further. Its NIRF 2026 return covers the batch that graduated in 2024-25, where 28 students completed in the stipulated time, 19 were placed, 9 went into higher studies, and the median salary reported for the placed graduates was Rs 20,41,360.

Read three years together and one column stops making sense.

The last row is more than ten times the one above it, which no pay revision explains, and the two earlier figures sit closer to a resident's monthly stipend than to an annual salary, so the three rows are unlikely to be measuring the same quantity. The latest is the figure the institute currently stands behind, and it is a median for those placed, not an offer anyone is owed. What the table does say consistently is that a growing share of each cohort leaves for further training rather than straight into practice, which is what you would expect of doctors finishing a broad specialty in a centre that also teaches the super-specialty above it.

GCRI's sanctioned postgraduate intake has risen in each of the three years it last reported. The NIRF 2026 submission puts the approved intake at 38 for 2024-25, against 34 in 2023-24 and 28 in 2022-23, with 100 students on the postgraduate roll, 75 of them from within Gujarat and 25 from outside the state. A year earlier the same return recorded 90 students on that roll, so the growth is real rather than a reporting artefact.

Sitting outside the degree count is a fellowship programme that GCRI runs and certifies itself, and for anyone who misses a NEET-SS seat it is the larger door into the same wards.

A GCRI fellowship is the institute's own certificate rather than a Gujarat University degree, so read it as supervised subspecialty training in the same wards and not as an equivalent of the DM or MCh sitting above it.

NIRF 2025 puts GCRI 44th of the 50 institutions in its medical list, on an overall score of 52.15, and the rank is the least informative part of the entry.

The teaching score of 88.71 is level with Madras Medical College and behind only four institutions on that list of 50, while the perception score of 7.00 is the third lowest and research and professional practice, at 14.30, sits among the lowest half dozen. Stated plainly, GCRI teaches like a top-five institution, publishes like one of the weakest on the table, and is recognised by almost nobody. That is close to what a single-disease hospital with no undergraduate batch would be expected to score, since perception surveys reach deans and employers who mostly deal in general medical colleges.

It is also worth noticing what GCRI is being measured against. It is not the only single-subject institution on the NIRF 2025 medical fifty, which also ranks NIMHANS in Bengaluru and the Institute of Liver and Biliary Sciences in Delhi, but it is the only cancer centre on it, and the rest of the table is general colleges teaching every specialty from anatomy upward. Against that field the teaching and graduation outcome columns are the only two where the comparison is close to fair.

The department list reads like a hospital's org chart, not a college's faculty roster. GCRI's annual report groups its clinical work under anaesthesiology, community oncology and medical records, gynaecological oncology, medical and paediatric oncology, palliative medicine, oncopathology with its own blood bank and microbiology units, radiodiagnosis with nuclear medicine and PET-CT, radiation oncology, surgical oncology, and neuro-oncology, and records the oncopathology department as NABH accredited. Surgical oncology alone runs six general units and six subspecialty ones, covering reconstructive and plastic surgery, urosurgery oncology, musculoskeletal oncosurgery, paediatric oncosurgery, ophthalmic oncosurgery and an interventional therapeutic centre.

Behind the wards sits the cancer biology research wing, and this is where the M.Sc. and PhD candidates work. It houses an immunohaematology laboratory, three molecular diagnostics and research laboratories and a cytogenetics laboratory, with all five accredited by the National Accreditation Board for Testing and Calibration Laboratories for diagnostic testing.

One unit that appears on no course list is worth a research candidate's attention. The Population Based Cancer Registry for the Ahmedabad urban agglomeration became operative at GCRI in 2007 under the Indian Council of Medical Research's National Cancer Registry Programme, and it gathers incidence and mortality data from more than 250 sources across the city. For anyone planning a dissertation here, that means population-level incidence and mortality figures for a whole city are compiled on the same premises as the wards supplying the cases.

The teaching equipment here is the treatment equipment, which is the argument for training at a dedicated centre rather than in an oncology wing of a general hospital. Radiation oncology alone runs four linear accelerators including a TrueBeam, a Bhabhatron II cobalt teletherapy machine, a Radixact tomotherapy unit, a Cyberknife, two HDR brachytherapy machines, and both a conventional and a CT simulator, and it is the same department that teaches the M.Sc. in Medical Physics and the CMRT certificate.

Scale has moved fast. The institute reported 1,000 beds and an average daily occupancy of 663 for the 2024 calendar year; its previous submission recorded 650 beds and an occupancy of 554 for 2022. At that strength the annual report calls GCRI the largest cancer hospital in the country, and it places several of its day-to-day services in a New Building on the Medicity site, so a trainee arriving now walks into a considerably bigger hospital than the one the earlier return describes.

The library is better provisioned than the institute's public profile suggests. It runs on SOUL 3.0 automation with a web catalogue, subscribes to the UpToDate clinical database, offers iThenticate plagiarism checking on the NCG platform, and added 61 oncology book titles and 47 journals in 2024-25, alongside a reading room kept for faculty and students.

Accessibility is where the record turns vague. The institute's ranking return puts lifts or ramps and specially designed toilets in more than 80% of the buildings without saying which ones, and on a campus where a trainee crosses between wards, laboratories and the radiation bunkers through the day, the gap in that answer is worth asking about on a visit.

GCRI publishes nothing about hostels. The annual report walks through the hospital estate department by department and never mentions where residents and paramedical students sleep, and the website carries no accommodation page and no charge sheet. What the campus is instead is a hospital block inside the Civil Hospital compound at Asarwa rather than a residential estate, and a resident on night duty in a cancer hospital of this size is not commuting anywhere, so the practical question at the offer stage is what the department can arrange on site and what it costs.

The list GCRI files with NIRF is the fullest headcount it publishes anywhere. Its 2026 submission names 101 teaching faculty, every one recorded as a regular appointment, against 81 in the submission a year earlier, and a large block of the newer names joined during 2024 and 2025 as the intake grew.

What the list does not carry is a single PhD-only academic. The qualifications column is almost entirely M.D., M.S., D.M., M.Ch. and DNB, which is what a faculty built out of practising oncologists looks like, and it means the person setting your assessment carries a theatre list or a chemotherapy day-care shift of their own. The director, Dr Shashank Pandya, heads a general surgical oncology unit himself and chairs the scientific review committee that scrutinises and approves every research activity in the institute, so the academic and clinical hierarchies here are one hierarchy.

Doctoral supervision is a smaller operation. The 2026 return shows seven full-time PhD scholars and two doctoral graduations in the year, so a research candidate here is joining a handful of people rather than a large graduate school.

GCRI publishes no roll of the specialists it has trained. Its annual report names faculty, prize winners, research fellows and committee members at length, yet the doctors who passed through its DM and MCh programmes leave holding a Gujarat University degree, and the hospitals that later hire them credit that degree rather than the ward it was earned on. Nothing in the institute's own record lets a named list be put together honestly, so there is none here.

The changes that matter at GCRI show up in its filings rather than in announcements. Its NIRF 2026 return shows the sponsored research portfolio shrinking to 8 projects funded by 3 agencies in 2024-25, worth Rs 1,43,42,320, from 15 projects and 7 agencies the year before. Anyone choosing this place for research rather than clinical volume should read that alongside the low NIRF research score rather than treat one year as a trend.

Clinical volume is going the other way. The hospital reported an average outpatient attendance of 901 a day in 2024, and its annual report for 2024-25 counts 26,290 new cancer and non-cancer registrations, 2,90,623 outpatient visits, 31,160 new admissions and an average inpatient stay of 7.91 days. For a trainee, that caseload is the real curriculum.

The most useful comparison is one the ranking table hands over. B J Medical College, the institution GCRI is affiliated to, sits 45th on the same NIRF 2025 medical list with an overall score of 51.84, one place below GCRI at 44th and 52.15. The two share a compound, a university and, for several subjects, a teaching arrangement, but they are not alternatives to each other: B J Medical College takes an MBBS batch and teaches the whole spread of broad specialties, while GCRI teaches oncology only and only above the MBBS line.

Set against everything else on that list, GCRI is the one cancer centre in it, so the comparison worth making is not on the NIRF page at all. It is the other regional and national cancer centres that train DM and MCh oncologists, and what separates them is the specific branch you want, the caseload standing behind it, and the NEET-SS rank that branch has been closing at. An overall medical rank does almost nothing for that decision.

GCRI sits inside the Civil Hospital campus at Asarwa in eastern Ahmedabad, on the site its annual report calls Medicity, next to the state's other tertiary hospitals.

The main line is a hunting number for the whole hospital and there is no separate admissions office, so an academic query goes faster if you ask for the department that teaches the course.

At a glance

Quick facts